Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
kathy.chan@immonc.ox.ac.uk
kathy.chan@oncology.ox.ac.uk

Research groups

Innate Sensing in the Tumour Microenvironment and Clinical Trials- Parkes Group

Kathy (Chung Ying) Chan

PhD

Postdoctoral Scientist

Recent publications

[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer.

Chan CY. et al, (2023), Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 64, 1965 - 1971

A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy.

Destro G. et al, (2023), Nuclear medicine and biology, 116-117

Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma.

Chan CY. et al, (2022), EJNMMI research, 12

Imaging PARP with [18F]rucaparib in pancreatic cancer models.

Chan CY. et al, (2022), European journal of nuclear medicine and molecular imaging, 49, 3668 - 3678

Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent.

Fraser CR. et al, (2022), EJNMMI research, 12

More publications